NL190746B - Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof. - Google Patents

Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof.

Info

Publication number
NL190746B
NL190746B NLAANVRAGE8203343,A NL8203343A NL190746B NL 190746 B NL190746 B NL 190746B NL 8203343 A NL8203343 A NL 8203343A NL 190746 B NL190746 B NL 190746B
Authority
NL
Netherlands
Prior art keywords
active ingredient
pharmaceutical preparation
delayed release
release active
ingredient pharmaceutical
Prior art date
Application number
NLAANVRAGE8203343,A
Other languages
English (en)
Other versions
NL190746C (nl
NL8203343A (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8203343A publication Critical patent/NL8203343A/nl
Publication of NL190746B publication Critical patent/NL190746B/nl
Application granted granted Critical
Publication of NL190746C publication Critical patent/NL190746C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8203343A 1981-09-14 1982-08-26 Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof. NL190746C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14
US30149881 1981-09-14

Publications (3)

Publication Number Publication Date
NL8203343A NL8203343A (nl) 1983-04-05
NL190746B true NL190746B (nl) 1994-03-01
NL190746C NL190746C (nl) 1994-08-01

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203343A NL190746C (nl) 1981-09-14 1982-08-26 Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof.

Country Status (11)

Country Link
JP (1) JPS5857315A (nl)
AT (1) AT385199B (nl)
BE (1) BE894376A (nl)
BG (1) BG60526B2 (nl)
CH (1) CH652025A5 (nl)
DE (1) DE3232873A1 (nl)
FR (1) FR2512676B1 (nl)
GB (1) GB2105590B (nl)
IT (1) IT1158048B (nl)
MX (1) MX9203173A (nl)
NL (1) NL190746C (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DE3642668A1 (de) * 1986-12-13 1988-06-23 Kamprad Joachim Schmerzmittel fuer menschen
EP0324947B2 (de) * 1987-12-31 1997-08-20 ASTA Medica Aktiengesellschaft Synergistische Kombination von Decarboxylasehemmern und L-Dopa-Pellets
ATE119766T1 (de) * 1989-10-26 1995-04-15 Nippon Shinyaku Co Ltd Zubereitung für den magen.
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
NZ274901A (en) * 1993-10-29 1997-03-24 Reckitt & Colmann Prod Ltd Chewable gelatin capsule for the treatment of gastric reflux or peptic ulceration comprising polymeric material, carbonate or bicarbonate salt and oil or hydrophilic based liquid vehicle
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
EP1560569A4 (en) * 2002-10-11 2006-03-22 Depomed Dev Ltd GASTRORETENTIVE LEVODOPA DELIVERY FORM
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
DE102014003744A1 (de) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (de) * 1961-06-16 1966-03-31 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinen
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
CH652025A5 (de) 1985-10-31
DE3232873A1 (de) 1983-03-31
GB2105590A (en) 1983-03-30
FR2512676B1 (fr) 1987-01-23
JPH0341447B2 (nl) 1991-06-24
AT385199B (de) 1988-02-25
GB2105590B (en) 1985-05-30
MX9203173A (es) 1992-07-01
FR2512676A1 (fr) 1983-03-18
JPS5857315A (ja) 1983-04-05
BG60526B2 (bg) 1995-07-28
BE894376A (fr) 1983-03-14
ATA341582A (de) 1987-08-15
NL190746C (nl) 1994-08-01
IT8223147A0 (it) 1982-09-07
IT1158048B (it) 1987-02-18
NL8203343A (nl) 1983-04-05

Similar Documents

Publication Publication Date Title
NL190746C (nl) Hydrodynamisch afgewogen farmaceutisch preparaat met vertraagde vrijmaking van werkzame stof.
NL300007I1 (nl) Preparaat voor de gereguleerde afgifte van een werkzame stof.
NO801863L (no) Farmasoeytiske preparater.
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
NL930039I2 (nl) Derivaten van cis, endo-2-azabicyclo-(3,3,0)-octaan-3-carbonzuur, werkwijze voor de bereiding daarvan, deze stoffen bevattende middelen en hun toepassing.
NL192430B (nl) Farmaceutisch preparaat voor vertraagde toediening van kalium.
NL193907B (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
NL189071C (nl) Cosmetisch preparaat.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NL187894C (nl) Contrastpreparaat voor angiografie.
FI822187L (fi) Farmaceutiska preparat
ES515375A0 (es) Procedimiento para la preparacion de derivados de 3-piridilo y 2-piracinilo.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
NL184833C (nl) 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.
ES517030A0 (es) Procedimiento para la preparacion de derivados de eburnamonina.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
ES517427A0 (es) Procedimiento para la preparacion de trioxidos de triamina.
IT8124241A0 (it) Formulazioni funghicide acquose eloro preparazione.
ES519351A0 (es) Procedimiento para la preparacion de benzotriazoles.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
NL7800097A (nl) Imidazool derivaten en werkwijzen voor de be- reiding en toepassing ervan.
DZ276A1 (fr) Préparations pharmaceutiques.
MC1371A1 (fr) Preparations pharmaceutiques
ES514394A0 (es) "procedimiento para la preparacion de metil terci-butileter o etilterci-butileter".
NL193821B (nl) Farmaceutisch preparaat.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BT A notification was added to the application dossier and made available to the public
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020826